Stock Details
FMS is Fresenius Medical Care AG & Co. KGaA's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 18.48$. Average daily volumn in 3 months 945.22k. Market cap 8.48B



Stock symbol : FMS. Exchange : NYSE. Currency : USD
Lastest price : 14.39$. Total volume : 1.11M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Fresenius Medical Care AG & Co. KGaA (FMS)
Last Price
14.39$
Change
-0.66
Volume
1.11M

Previous Close15.05
Open14.57
Day Range14.16-14.65
Bid14.03 x 1.2k
Ask14.52 x 1.8k
Volume1.11M
Average Volume945.22k
Market Cap8.48B
Beta0.90
52 Week Range14.16-36.08
Trailing P/E10.50
Foward P/E5.95
Dividend (Yield %)4.92%
Ex-Dividend Date2022-05-13



Financial Details


According to Fresenius Medical Care AG & Co. KGaA's financial reports the company's revenue in 2021 were 17.62B an decrease(0%) over the years 2020 revenue that were of 17.86B. In 2021 the company's total earnings were 969.31M while total earnings in 2020 were 1.16B(-3.1%).


Loading ...



Organization

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the... United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Market Cap:
8.48B
Revenue:
17.62B
Total Assets:
34.37B
Total Cash:
1.48B


News about "Fresenius Medical Care AG & Co. KGaA"

fresenius-medical-care-ag-co-kgaa-nysefms-coverage-initiated-by-analysts-at-stocknewscom-image

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Coverage Initiated by Analysts at StockNews.com

Source from : Defense World - 2 days ago

Equities research analysts at StockNews.com began coverage on shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS โ€“ Get Rating) in a note issued to investors on Saturday. The firm set a โ€œholdโ€ ...See details»


Fresenius Medical Care AG & Co. KGaA ADR

Source from : Wall Street Journal - 12 days ago

Lundbeck A/S, Dentsply Sirona, Inc. A. Gregory Sorensen Member-Supervisory Board Fresenius Medical Care AG & Co. KGaA, Empresa de Servicios Sanitarios de Los Lagos SA, IMRIS, Inc., Fusion ...See details»


buy-or-sell-fresenius-medical-care-ag-co-kgaa-fms-stock-now-dont-try-to-be-a-top-gun-image

Buy or Sell Fresenius Medical Care AG & Co. KGaA (FMS) Stock Now | Donโ€™t Try to Be a Top Gun

Source from : newsheater - 16 days ago

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) went down by -4.34% from its latest closing price compared to the recent 1-year high of $38.74. The companyโ€™s stock price has collected -4.62% of loss ...See details»


Fresenius Medical (FMS) Robust Product Portfolio Drives Growth

Source from : Nasdaq - 1 month ago

Fresenius Medical Care AG & Co. KGaA FMS is one of the largest integrated providers of products and services for individuals undergoing dialysis following chronic kidney failure. Through its ...See details»


Fresenius Medical Care (NYSE: FMS)

Source from : The Motley Fool - 11 days ago

The company makes and sells products for all forms of kidney dialysis to health-care providers throughout the world, along with providing kidney dialysis treatment and other medical ancillary ...See details»


Hemodialysis Peritoneal Dialysis Market In-deep Analysis And Experts Review Report 2022-2029 โ€“ Fresenius Medical Care AG and Co. KGAA

Source from : MarketWatch - 4 days ago

The Global Hemodialysis Peritoneal Dialysis Market Size was estimated at USD 62128.27 million in 2021 and is projected to reach USD 78692.35 million by 2028, exhibiting a CAGR of 3.43% during the ...See details»


Fresenius Medical Care partners with National Kidney Foundation Malaysia in kidney health initiative

Source from : Stockhouse - 18 days ago

These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does ...See details»


NxStage from Fresenius Medical Care Launches...

Source from : Benzinga.com - 1 month ago

These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co ...See details»


Analysts Forecast 18% Upside For PID

Source from : Nasdaq - 5 days ago

With PID trading at a recent price near $16.73 per unit, that means that analysts see 18.47% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of PID ...See details»


Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius

Source from : Yahoo UK & Ireland - 1 month ago

Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm ... transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.See details»


Fluid Management System Market โ€“ Growth, Trends, Covid-19 Impact, And Forecasts 2022 โ€“ 2030

Source from : MarketWatch - 6 days ago

Some of the major market participants include Cardinal Health, Inc., Stryker Corporation, Karl Storz GmbH & Co. Kg, Zimmer Biomet Holdings, Inc., Baxter International Inc., Becton, Dickinson and ...See details»


Fresenius Kidney Care Celebrates Nephrology Nurses Week with The CARE Award

Source from : Stockhouse - 13 days ago

About Fresenius Kidney Care Fresenius Kidney Care, a division of Fresenius Medical Care North America (FMCNA), provides kidney disease education, dialysis treatment, and support services to more than ...See details»


Dialyzer Market Recorded a 6.40% Y-O-Y Growth Rate in 2021, Evolving Opportunities with Asahi Kasei Corp. & B. Braun Melsungen AG - Technavio

Source from : Yahoo Finance - 1 month ago

NEW YORK, Aug. 26, 2022 /PRNewswire/ -- The dialyzer market size is set to grow by USD 3.36 billion from 2020 to 2025, progressing at a CAGR of 6.8% according to Technavio. Also, the market ...See details»


Smart Infusion Pump Market with Tremendous growth by 2029 Fresenius Kabi AG, Q Core Medical Ltd., Becton

Source from : Digital Journal - 14 days ago

Some of the Top companies Influencing this Market include:Fresenius Kabi AG, Q Core Medical Ltd., Becton, Dickinson and Company, Micrel Medical Devices SA, Baxter International, Inc., Smiths ...See details»